59 related articles for article (PubMed ID: 38541076)
1. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
[TBL] [Abstract][Full Text] [Related]
2. Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer.
Sun L; Liu R; Wu ZJ; Liu ZY; Wan AH; Yan S; Liu C; Liang H; Xiao M; You N; Lou Y; Deng Y; Bu X; Chen D; Huang J; Zhang X; Kuang DM; Wan G
Gastroenterology; 2024 Mar; 166(3):466-482. PubMed ID: 38065340
[TBL] [Abstract][Full Text] [Related]
3. Shaping immune landscape of colorectal cancer by cholesterol metabolites.
Bai Y; Li T; Wang Q; You W; Yang H; Xu X; Li Z; Zhang Y; Yan C; Yang L; Qiu J; Liu Y; Chen S; Wang D; Huang B; Liu K; Song BL; Wang Z; Li K; Liu X; Wang G; Yang W; Chen J; Hao P; Zhang Z; Wang Z; Zhu ZJ; Xu C
EMBO Mol Med; 2024 Feb; 16(2):334-360. PubMed ID: 38177537
[TBL] [Abstract][Full Text] [Related]
4. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
[TBL] [Abstract][Full Text] [Related]
5. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
6. Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy.
Kibriya MG; Jasmine F; Khamkevych Y; Raza M; Kamal M; Bissonnette M; Ahsan H
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541076
[No Abstract] [Full Text] [Related]
7. Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan.
Lin CH; Lin JK; Chang SC; Chang YH; Chang HM; Liu JH; Li LH; Chen YT; Tsai SF; Chen WS
J Biomed Sci; 2011 Jun; 18(1):36. PubMed ID: 21645411
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
Akbari V; Kallhor M; Mollashahi B; Movafagh A
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
[TBL] [Abstract][Full Text] [Related]
9. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer.
Yu C; Hong H; Zhang S; Zong Y; Ma J; Lu A; Sun J; Zheng M
Mol Med Rep; 2019 Mar; 19(3):2065-2076. PubMed ID: 30664178
[TBL] [Abstract][Full Text] [Related]
10. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
11. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
[TBL] [Abstract][Full Text] [Related]
12. PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies.
Lin KX; Istl AC; Quan D; Skaro A; Tang E; Zheng X
Cancer Immunol Immunother; 2023 Dec; 72(12):3875-3893. PubMed ID: 37831146
[TBL] [Abstract][Full Text] [Related]
13. Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study.
Kibriya MG; Jasmine F; Pekow J; Munoz A; Weber C; Raza M; Kamal M; Ahsan H; Bissonnette M
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296884
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Landscapes in Colorectal Carcinoma.
Scanu AM; De Miglio MR
Medicina (Kaunas); 2023 Apr; 59(5):. PubMed ID: 37241053
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Hegde M; Girisa S; BharathwajChetty B; Vishwa R; Kunnumakkara AB
ACS Omega; 2023 Mar; 8(12):10713-10746. PubMed ID: 37008131
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]